Biolife Solutions Stock Buy Hold or Sell Recommendation
| BLFS Stock | USD 27.06 0.29 1.08% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding BioLife Solutions is 'Cautious Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell BioLife Solutions given historical horizon and risk tolerance towards BioLife Solutions. When Macroaxis issues a 'buy' or 'sell' recommendation for BioLife Solutions, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out BioLife Solutions Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide. Note, we conduct extensive research on individual companies such as BioLife and provide practical buy, sell, or hold advice based on investors' constraints. BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
BioLife |
Execute BioLife Solutions Buy or Sell Advice
The BioLife recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on BioLife Solutions. Macroaxis does not own or have any residual interests in BioLife Solutions or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BioLife Solutions' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Insignificant | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
BioLife Solutions Trading Alerts and Improvement Suggestions
| BioLife Solutions had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 143.27 M. Net Loss for the year was (66.43 M) with profit before overhead, payroll, taxes, and interest of 54.07 M. | |
| BioLife Solutions currently holds about 46.55 M in cash with (12.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.09. | |
| BioLife Solutions has a frail financial position based on the latest SEC disclosures | |
| Over 100.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: BioLife Solutions Stock Price Up 6.7 percent Heres What Happened |
BioLife Solutions Returns Distribution Density
The distribution of BioLife Solutions' historical returns is an attempt to chart the uncertainty of BioLife Solutions' future price movements. The chart of the probability distribution of BioLife Solutions daily returns describes the distribution of returns around its average expected value. We use BioLife Solutions price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of BioLife Solutions returns is essential to provide solid investment advice for BioLife Solutions.
| Mean Return | 0.16 | Value At Risk | -5.6 | Potential Upside | 6.19 | Standard Deviation | 3.77 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of BioLife Solutions historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
BioLife Stock Institutional Investors
The BioLife Solutions' institutional investors refer to entities that pool money to purchase BioLife Solutions' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Geneva Capital Management | 2024-09-30 | 865.3 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 846.6 K | Geode Capital Management, Llc | 2024-09-30 | 842.8 K | Royce & Associates, Lp | 2024-09-30 | 825.1 K | Palisade Capital Management Llc | 2024-09-30 | 821.1 K | Granahan Investment Management Inc.. | 2024-09-30 | 658.6 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 584.3 K | Gagnon Securities Llc | 2024-09-30 | 569.4 K | Bank Of America Corp | 2024-06-30 | 544.1 K | Casdin Capital, Llc | 2024-09-30 | 8.7 M | Blackrock Inc | 2024-06-30 | 5.5 M |
BioLife Solutions Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (24.2M) | 84.0M | (20.6M) | (50.4M) | 16.0M | 16.8M | |
| Free Cash Flow | 538K | 1.9M | (13.2M) | (18.9M) | (18.9M) | (17.9M) | |
| Depreciation | 1.8M | 5.1M | 12.9M | 16.5M | 12.3M | 12.9M | |
| Other Non Cash Items | 4.0M | (2.1M) | (364K) | 109.7M | 8.6M | 9.0M | |
| Capital Expenditures | 675K | 4.6M | 8.4M | 10.4M | 6.4M | 6.7M | |
| Net Income | (1.7M) | 2.7M | (7.6M) | (139.8M) | (66.4M) | (63.1M) | |
| End Period Cash Flow | 6.4M | 90.5M | 69.9M | 19.5M | 35.4M | 37.2M | |
| Change To Inventory | (3.8M) | (629K) | 114K | (6.6M) | (8.6M) | (8.1M) | |
| Change Receivables | 172.3K | (2.0M) | (290K) | (1.8M) | (1.6M) | (1.5M) | |
| Net Borrowings | 979.8K | (56K) | 984K | (2.9M) | (2.6M) | (2.5M) | |
| Change To Netincome | 15.0M | (1.2M) | (9.0M) | 114.8M | 132.0M | 138.6M | |
| Investments | 1M | (23.7M) | (12.6M) | (58.1M) | (1.0M) | (1.1M) |
BioLife Solutions Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BioLife Solutions or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BioLife Solutions' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BioLife stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.06 | |
β | Beta against Dow Jones | 1.73 | |
σ | Overall volatility | 3.81 | |
Ir | Information ratio | 0.01 |
BioLife Solutions Volatility Alert
BioLife Solutions shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure BioLife Solutions' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact BioLife Solutions' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.BioLife Solutions Fundamentals Vs Peers
Comparing BioLife Solutions' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BioLife Solutions' direct or indirect competition across all of the common fundamentals between BioLife Solutions and the related equities. This way, we can detect undervalued stocks with similar characteristics as BioLife Solutions or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of BioLife Solutions' fundamental indicators could also be used in its relative valuation, which is a method of valuing BioLife Solutions by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BioLife Solutions to competition |
| Fundamentals | BioLife Solutions | Peer Average |
| Return On Equity | -0.15 | -0.31 |
| Return On Asset | -0.0597 | -0.14 |
| Profit Margin | (0.31) % | (1.27) % |
| Operating Margin | (0.05) % | (5.51) % |
| Current Valuation | 1.25 B | 16.62 B |
| Shares Outstanding | 46.39 M | 571.82 M |
| Shares Owned By Insiders | 1.93 % | 10.09 % |
| Shares Owned By Institutions | 99.56 % | 39.21 % |
| Number Of Shares Shorted | 3.5 M | 4.71 M |
| Price To Earning | 173.59 X | 28.72 X |
| Price To Book | 3.82 X | 9.51 X |
| Price To Sales | 8.45 X | 11.42 X |
| Revenue | 143.27 M | 9.43 B |
| Gross Profit | 54.07 M | 27.38 B |
| EBITDA | (45.24 M) | 3.9 B |
| Net Income | (66.43 M) | 570.98 M |
| Cash And Equivalents | 46.55 M | 2.7 B |
| Cash Per Share | 1.09 X | 5.01 X |
| Total Debt | 42.69 M | 5.32 B |
| Debt To Equity | 0.06 % | 48.70 % |
| Current Ratio | 3.55 X | 2.16 X |
| Book Value Per Share | 7.04 X | 1.93 K |
| Cash Flow From Operations | (12.5 M) | 971.22 M |
| Short Ratio | 13.43 X | 4.00 X |
| Earnings Per Share | (1.11) X | 3.12 X |
| Price To Earnings To Growth | 65.38 X | 4.89 X |
| Target Price | 29.8 | |
| Number Of Employees | 409 | 18.84 K |
| Beta | 1.88 | -0.15 |
| Market Capitalization | 1.24 B | 19.03 B |
| Total Asset | 412.71 M | 29.47 B |
| Retained Earnings | (313.34 M) | 9.33 B |
| Working Capital | 78.43 M | 1.48 B |
Note: Disposition of 894 shares by Troy Wichterman of BioLife Solutions at 23.15 subject to Rule 16b-3 [view details]
BioLife Solutions Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BioLife . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 26610.79 | |||
| Daily Balance Of Power | 0.2458 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 26.82 | |||
| Day Typical Price | 26.9 | |||
| Price Action Indicator | 0.38 | |||
| Period Momentum Indicator | 0.29 |
About BioLife Solutions Buy or Sell Advice
When is the right time to buy or sell BioLife Solutions? Buying financial instruments such as BioLife Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having BioLife Solutions in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Government Funds Thematic Idea Now
Government Funds
Funds or Etfs that invest in fixed income securities issued by national government to finance government spending or to facilitate Federal Reserve monetary policies. The Government Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Government Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.